Regulation of the MAD1 promoter by G-CSF

Nucleic Acids Research

Volumn 36, Issue 5, 2008, Pages 1517-1531

  Jiang, Kan ^a   Hein, Nadine ^a   Eckert, Kolja ^a   Lüscher Firzlaff, Juliane ^a   Lüscher, Bernhard ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CYTOSINE; DNA; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GUANINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN MAD1; RAF PROTEIN; RAS PROTEIN; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CHROMATIN; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GC RICH SEQUENCE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; RAT; REPORTER GENE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TATA BOX; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CHROMATIN; GENES, REPORTER; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; REPRESSOR PROTEINS; RESPONSE ELEMENTS; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS);

RATTUS;

EID: 41149099640     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn002     Document Type: Article

References (70)

1. Adhikary,S. and Eilers,M. (2005) Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell. Biol., 6 635-645.
2. Grandori,C., Cowley,S.M., James,L.P. and Eisenman,R.N. (2000) The Myc/ Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol., 16, 653-699.
3. Luscher,B. (2001) Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene, 277, 1-14.
4. Oster,S.K., Ho,C.S., Soucie,E.L. and Penn,L.Z. (2002) The myc oncogene: MarvelouslY Complex. Adv. Cancer Res., 84, 81-154.
5. Luscher,B. and Larsson,L.G. (1999) The basic region/helix-loop-helix/ leucine zipper domain of Myc proto-oncoproteins: Function and regulation. Oncogene, 18, 2955-2966.
6. Cole,M.D. and Nikiforov,M.A. (2006) Transcriptional activation by the Myc oncoprotein. Curr. Top. Microbiol. Immunol., 302, 33-50.
7. Rottmann,S. and Luscher,B. (2006) The mad side of the Max network: antagonizing the function of Myc and more. Curr. Top. Microbiol. Immunol., 302, 63-122.
8. Cerni,C., Bousset,K., Seelos,C., Burkhardt,H., Henriksson,M. and Luscher,B. (1995) Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene, 11, 587-596.
9. Cerni,C., Skrzypek,B., Popov,N., Sasgary,S., Schmidt,G., Larsson,L.G., Luscher,B. and Henriksson,M. (2002) Repression of in vivo growth of Myc/ Ras transformed tumor cells by Madl. Oncogene, 21, 447-459.
10. Hurlin,P.J., Queva,C. and Eisenman,R.N. (1997) Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev., 11 44-58.
11. Hurlin,P.J., Queva,C., Koskinen,P.J., Steingrimsson,E., Ayer,D.E., Copeland,N.G., Jenkins,N.A. and Eisenman,R.N. (1995) Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent-transformation and are expressed during neural and epidermal differentiation. EMBO J., 14, 5646-5659.
12. Hurlin,P.J., Steingrimsson,E., Copeland,N.G., Jenkins,N.A. and Eisenman,R.N. (1999) Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. EMBO J. 18, 7019-7028.
13. Koskinen,P.J., Ayer,D.E. and Eisenman,R.N. (1995) Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Cell Growth Differ., 6, 623-629.
14. Lahoz,E.G., Xu,L., Schreiber-Agus,N. and DePinho,R.A. (1994) Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc. Natl Acad. Sci. USA, 91, 5503-5507.
15. Schreiber-Agus,N., Chin,L., Chen,K., Torres,R., Rao,G., Guida,P., Skoultchi,A.I. and DePinho,R.A. (1995) An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell, 80, 777-786.
16. Vastrik,I., Kaipainen,A., Penttila,T.L., Lymboussakis,A., Alitalo,R., Parvinen,M. and Alitalo,K. (1995) Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. Cell. Biol., 128, 1197-1208.
17. Schreiber-Agus,N., Meng,Y., Hoang,T., Hou,H. Jr, Chen,K., Greenberg,R., Cordon-Cardo,C., Lee,H.W. and DePinho,R.A. (1998) Role of Mxil in ageing organ systems and the regulation of normal and neoplastic growth. Nature, 393, 483-487.
18. Chen,J., Willingham,T., Margraf,L.R., Schreiber-Agus,N., DePinho,R.A. and Nisen,P.D. (1995) Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat. Med., 1, 638-643.
19. Cultraro,C.M., Bino,T. and Segal,S. (1997) Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation. Mol. Cell Biol., 17, 2353-2359.
20. Gehring,S., Rottmann,S., Menkel,A.R., Mertsching,J., Krippner-Heidenreich,A. and Luscher,B. (2000) Inhibition of proliferation and apoptosis by the transcriptional repressor Mad1. Repression of Fas-induced caspase-8 activation. J. Biol. Chem., 275, 10413-10420.
21. Pulverer,B., Sommer,A., McArthur,G.A., Eisenman,R.N. and Luscher,B. (2000) Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1. J. Cell Physiol., 183, 399-410.
22. Roussel,M.F., Ashmun,R.A., Sherr,C.J., Eisenman,R.N. and Ayer,D.E. (1996) Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol. Cell. Biol., 16, 2796-2801.
23. Sommer,A., Hilfenhaus,S., Menkel,A., Kremmer,E., Seiser,C., Loidl,P. and Luscher,B. (1997) Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr. Biol., 7, 357-365.
24. Rottmann,S., Speckgens,S., Luscher-Firzlaff,J. and Luscher,B. (2007) Inhibition of apoptosis by MAD1 is mediated by repression of the PTEN tumor suppressor gene. FASEB J., doi: 10.1096/fj.07-9627com.
25. Queva,C., McArthur,G.A., Ramos,L.S. and Eisenman,R.N. (1999) Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1. Cell Growth Differ., 10, 785-796.
26. Foley,K.P., McArthur,G.A., Queva,C., Hurlin,P.J., Soriaire,P. and Eisenman,R.N. (1998) Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J 17, 774-785.
27. Ayer,A.E. and Eisenman,R.N. (1993) A switch from Myc:MAx to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev., 7, 2110-2119.
28. Ayer,D.E., Kretzner,L. and Eisemnan,R.N. (1993) Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72, 211-222.
29. Larsson,L.G., Bahram,F., Burkhardt,H. and Luscher,B. (1997) Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Oncogene, 15, 737-748.
30. Larsson,L.G., Pettersson,M., Oberg,F., Nilsson,K. and Luscher,B. (1994) Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: Opposite regulation of mad and c-myc. Oncogene 9, 1247-1252.
31. Lymboussaki,A., Kaipainen,A., Hatva,E., Vastrik,I., Jeskanen,L., Jalkanen,M., Werner,S., Stenback,F. and Alitalo,R. (1996) Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. Br. J. Cancer, 73, 1347-1155.
32. Sommer,A., Bousset,K., Kremmer,E., Austen,M. and Luscher,B. (1998) Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators. J. Biol. Chem., 273, 6632-6642.
33. Werner,S., Beer,H.D., Mauch,C. and Luscher,B. (2001) The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: Possible role of Mad1 in wound repair and psoriasis. Oncogene, 20, 7494-7504.
34. Avalos,B.R. (1996) Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood, 88, 761-777.
35. Touw,I.P. and van de Geijn,G.J. (2007) Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders. Front. Biosci., 12, 800-815.
36. van de Geijn,G.J., Aarts,L.H., Erkeland,S.J., Prasher,J.M. and Touw,I.P. (2003) Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease. Rev. Physiol. Biochem. Pharmacol., 149, 53-71.
37. de Koning,J.P., Soede-Bobok,A.A., Schelen,A.M., Smith,L., van Leeuwen,D., Santini,V., Burgering,B.M., Bos,J.L., Lowenberg,B. and Touw,I.P. (1998) Proliferation signaling and activation of Shc, p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood, 91, 1924-1933.
38. Hermans,M.H., van de Geijn,G.J., Antonissen,C., Gits,J., van Leeuwen,D., Ward,A.C. and Touw,I.P. (2003) Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood, 101 2584-2590.
39. Rausch,O. and Marshall,C.J. (1997) Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol. Cell Biol., 17, 1170-1179.
40. Shao,H., Xu,X., Jing,N. and Tweardy,D.J. (2006) Unique structural determinants for Stat3 recruitment and activation by the granulocyte colony-stimulating factor receptor at phosphotyrosine ligands 704 and 744. J. Immunol., 176, 2933-2941.
41. Ward,A.C., Hermans,M.H., Smith,L., van Aesch,Y.M., Schelen,A.M., Antonissen,C. and Touw,I.P. (1999) Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. Blood, 93, 113-124.
42. Iida,S., Kohro,T., Kodama,T., Nagata,S. and Fukunaga,R. (2005) Identification of CCR2, flotillin, and gp49B genes as new G-CSF targets during neutrophilic differentiation. J. Leukoc. Biol., 78, 481-490.
43. Liu,X.L., Yuan,J.Y., Zhang,J.W., Zhang,X.H. and Wang,R.X. (2007) Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage. J. Leukoc. Biol., 82, 986-1002.
44. Redell, M.S., Tsimelzon,A., Hilsenbeck,S.G. and Tweardy,D.J. (2007) Conditional overexpression of Stat3{alpha} in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern. J. Leukoc. Biol., 82, 975-985.
45. Croker,B.A., Metcalf.D., Robb,L., Wei,W., Mifsud,S., DiRago,L., Cluse,L.A., Sutherland,K.D., Hartley,L. et al. (2004) SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity, 20, 153-165.
46. Irandoust,M.I., Aarts,L.H., Roovers,O., Gits,J., Erkeland,S.J. and Touw,I.P. (2007) Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor. EMBO J., 26, 1782-1793.
47. Zhuang,D., Qiu,Y., Haque,S.J. and Dong,F. (2005) Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: Involvement of SOCS3 and SOCS1. J. Leukoc. Biol., 78, 1008-1015.
48. Luscher-Firzlaff,J.M., Westendorf,J.M., Zwicker,J., Burkhardt,H., Henriksson,M., Muller,R., Pirollet,F. and Luscher,B. (1999) Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: Enhancement of transformation and transactivation. Oncogene, 18, 5620-5630.
49. Oelgeschlager,M., Nuchprayoon,I., Luscher,B. and Friedman,A.D. (1996) C/ EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell. Biol., 16, 4717-4725.
50. Bouchard,C., Dittrich,O., Kiermaier,A., Dohmann,K., Menkel,A., Eilers,M. and Luscher,B. (2001) Regulation of cyclin D2 gene expression by the Myc/ Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev., 15, 2042-2047.
51. Sandelin,A., Carninci,P., Lenhard,B., Ponjavic,J., Hayashizaki,Y. and Hume,D.A. (2007) Mammalian RNA polymerase II core promoters: Insights from genome-wide studies. Nat. Rev. Genet., 8, 424-436.
52. Herbst,A., Koester,M., Wirth,D., Hauser,H. and Welte,K. (1999) G-CSF receptor mutations in patients with severe congenital neutropenia do not abrogate Jak2 activation and stat1/stat3 translocation. Ann. NY. Acad. Sci., 872, 320-325; discussion 325-327.
53. Chakraborty,A., Dyer,K.F., Cascio,M., Mietzner,T.A. and Tweardy,D.J. (1999) Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor. Blood, 93, 15-24.
54. Friedman,A.D. (2002) Transcriptional regulation of granulocyte and monocyte development. Oncogene, 21, 3377-3390.
55. Nerlov,C. (2007) The C/EBP family of transcription factors: A paradigm for interaction between gene expression and proliferation control. Trends Cell. Biol., 17, 318-324.
56. Antequera,F. (2003) Structure, function and evolution of CpG island promoters. Cell Mol. Life Sci., 60, 1647-1658.
57. Suske,G. (1999) The Sp-family of transcription factors. Gene, 238, 291-300.
58. Benson,L.Q., Coon,M.R., Krueger,L.M., Han,G.C., Sarnaik,A.A. and Wechsler,D.S. (1999) Expression of MXI1, a Myc antagonist, is regulated by Sp1 and AP2. J. Biol. Chem., 274, 28794-28802.
59. Fox,E.J. and Wright,S.C. (2003) The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1. Biochem J, 370, 307-313.
60. Kime,L. and Wright,S.C. (2003) Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc. Biochem. J., 370, 291-298.
61. Fox,E.J. and Wright,S.C. (2001) S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells. Biochem. J., 359, 361-367.
62. Dimova,D.K. and Dyson,N.J. (2005) The E2F transcriptional network: Old acquaintances with new faces. Oncogene, 24, 2810-2826.
63. Merika,M. and Thanos,D. (2001) Enhanceosomes. Curr. Opin. Genet. Dev. 11, 205-208.
64. Scott,L.M., Civin,C.I., Rorth,P. and Friedman,A.D. (1992) A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood, 80, 1725-1735.
65. Zhang,D.E., Zhang,P., Wang,N.D., Hetherington,C.J., Darlington,G.J. and Tenen,D.G. (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc. Natl Acad. Sci. USA, 94, 569-574.
66. Morosetti,R., Park,D.J., Chumakov,A.M., Grillier,I., Shiohara,M., Gombart,A.F., Nakamaki,T., Weinberg,K. and Koeffler,H.P. (1997) A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. Blood, 90, 2591-2600.
67. Yamanaka,R., Kim,G.D., Radomska,H.S., Lekstrom-Himes,J., Smith,L.T., Antonson,P., Tenen,D.G. and Xanthopoulos,K.G. (1997) CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc. Natl Acad. Sci. USA, 94, 6462-6467.
68. Screpanti,I., Romani,L., Musiani,P., Modesti,A., Fattori,E., Lazzaro,D., Sellitto,C., Scarpa,S., Bellavia,D. et al. (1995) Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J., 14, 1932-1941.
69. Akagi,T., Saitoh,T., O'Kelly,J., Akira,S., Gombart,A.F. and Koeffler,H.P. (2007) Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBP{beta}-deficient hematopoietic cells. Blood, doi: 10.1182/blood-2007-04-087213.
70. Numata,A., Shimoda,K., Kamezaki,K., Haro,T., Kakumitsu,H., Shide,K., Kato,K., Miyamoto,T., Yamashita,Y. et al. (2005) Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway. J. Biol. Chem., 280, 12621-12629.